**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 28446-68-6 |4-Methoxycinnamonitrile, Mixture of Ci| 98% | 249-022-4 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation and in contact with skin.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be metabolized to cyanide which in
turn acts by inhibiting cytochrome oxidase impairing cellular
respiration.
Ingestion:
May cause irritation of the digestive tract. May cause cardiac
disturbances. Metabolism may release cyanide, which may result in
headache, dizziness, weakness, collapse, unconsciousness and possible
death. Ingestion of large amounts may produce central nervous system
depression, headache, dizziness, diarrhea, and possible hemorrhagic
gastroenteritis.
Inhalation:
May cause respiratory tract irritation. May cause cardiac
abnormalities. May be metabolized to cyanide which in turns act by
inhibiting cytochrome oxidase impairing cellular respiration.
Inhalation at high concentrations may cause CNS depression and
asphixiation.
Chronic:
No information found. May be metabolized to cyanide which in turn
acts by inhibiting cytochrome oxidase impairing cellular
respiration. Chronic exposure to cyanide solutions may lead to the
development of a "cyanide" rash, characterized by itching, and by
macular, papular, and vesicular eruptions, and may be accompanied by
secondary infections. Exposure to small amounts of cyanide compounds
over long periods of time is reported to cause loss of appetite,
headache, weakness, nausea, dizziness, and symptoms of irritation of
the upper respiratory tract and eyes.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing
is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
May be partially metabolized to cyanide in the body.
Antidote:
Always have a cyanide antidote kit on hand when working with cyanide
compounds. Get medical advice to use.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Runoff from
fire control or dilution water may cause pollution.
Extinguishing Media:
Use agent most appropriate to extinguish fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 28446-68-6:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: after melting, clear yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 127 - 140 deg C @ 1.00mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H9NO
Molecular Weight: 159.19
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide, cyanide fumes.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 28446-68-6: GE1459320
LD50/LC50:
Not available.
Carcinogenicity:
4-Methoxycinnamonitrile, Mixture of Cis/Trans -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
IMO
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
RID/ADR
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21 Harmful by inhalation and in contact with
skin.
Safety Phrases:
S 23 Do not inhale gas/fumes/vapour/spray.
WGK (Water Danger/Protection)
CAS# 28446-68-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 28446-68-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 28446-68-6 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Formic acid-d2, 99+ atom % D (95% in D2O)
| 64-18-6 |
|
Barium fluoride
| 7787-32-8 |
|
m-Tolyl isothiocyanate, 98%
| 621-30-7 |
|
2,5-Dimethyl-2,5-hexanediol, 99%
| 110-03-2 |
|
Dibenz[a,h]anthracene, 99% (UV-Vis)
| 53-70-3 |
|
Basic Fuchsin, high purity biological stain, special for flagella
| 58969-01-0 |
|
1-Chloro-3,5-Difluorobenzene
| 1435-43-4 |
|
Decanoic Acid, 99+%
| 334-48-5 |
|
Cholesteryl N-Heptylate, 97%
| 1182-07-6 |
|
N-(1-Adamantyl)-Urea
| 13072-69-0 |
|
2-Thiopheneacetic acid, 98%
| 1918-77-0 |
|
N-Formylmorpholine, 99+%
| 4394-85-8 |
|
2-Thiophenecarboxaldehyde, 98%
| 98-03-3 |
|
Poly(tetrafluoroethylene)
| 9002-84-0 |
|
1,1-Dimethyl-2-Selenourea, 97%
| 5117-16-8 |
|
2-Bromopropionyl chloride, tech.
| 7148-74-5 |
|
Cyclopropanecarboxylic Acid Chloride, 98% (GC)
| 4023-34-1 |
|
Diethyl 3-oxopimelate, 97%
| 40420-22-2 |
|
2,4-Dichlorophenylhydrazine Hydrochloride 99%
| 5446-18-4 |
|
4-Aminobenzonitrile,98%
| 873-74-5 |
|
1-Adamantanecarboxylic Acid Chloride, 97+%
| 2094-72-6 |
|
4-Methoxycinnamonitrile 98% Mixture of Cis/Trans
| 28446-68-6 |
|
1,4-Epoxy-1,4-dihydronaphthalene, 99%
| 573-57-9 |
|
3-Cyclohexylpropionic Acid, 99+%
| 701-97-3 |
|
Thymidine, 99+%
| 50-89-5 |
|
1-Chloro-3-fluorobenzene, 99%
| 625-98-9 |
|
4-Bromo-2-fluoroaniline, 99%
| 367-24-8 |
|
4-(4-Nitrophenylazo)-resorcinol dye content ~90%
| 74-39-5 |
|
Vinylcyclohexane, 98%
| 695-12-5 |
|
Diethyl propylmalonate, 99%
| 2163-48-6 |
|
N,N-Bis-(2-Chloroethyl)-P-Toluenesulfonamide, Tech.
| 42137-88-2 |
|
Pyrazole, 98%
| 288-13-1 |
|
Carbon Tetrachloride, 99+%, Spectrophotometric Grade
| 56-23-5 |
|
1,1-Dimethylcyclohexane, 97%
| 590-66-9 |
|
Dimethyl 4,5-imidazoledicarboxylate, 93% (uv-vis)
| 3304-70-9 |
|
Cyclooctylamine, 97%
| 5452-37-9 |
|
Tolylene-2,6-Diisocyanate, 97%
| 91-08-7 |
|
3-Fluorophenylhydrazine Hydrochloride 97%
| 2924-16-5 |
|
1-Iodonaphthalene, 97.5% (GC)
| 90-14-2 |
|
L-(+)-Amethopterin hydrate, 99%
| 133073-73-1 |
|
Cyclopentanone
| 120-92-3 |
|
n-Phenylbenzohydroxamic acid, 98% (titr.)
| 304-88-1 |
|
3-Benzoylacrylic acid
| 583-06-2 |
|
Phenylhydroquinone, 96%
| 1079-21-6 |
|
BOC-L-Histidine, 99+%
| 17791-52-5 |
|
3-Methyl-2-Nitroanisole, 99%
| 5345-42-6 |
|
Cytidine, 99.5%
| 65-46-3 |
|
Ethyl (2s)-2,3-epoxypropanoate, 97%
| 111058-34-5 |
|
Vinylbenzyl Chloride (Mixt. of m-and p-Isomers), 96% (GC), Stabilized
| 57458-41-0 |
|
3-Ethyl-2,5-dihydrothiophene-1,1-dioxide, 98%
| 62157-91-9 |
|
|